Mylan Inc (MYL)

MYL (NASDAQ:Drugs)
$31.40
neg -0.35
-1.10%
Today's Range: 31.22 - 31.69 | MYL Avg Daily Volume: 6,223,800
Last Update: 05/24/13 - 12:00 PM EDT
Volume: 1,819,165
YTD Performance: 14.94%
Open: $31.69
Previous Close: $31.75
52 Week Range: $20.50 - $32.09
Oustanding Shares: 381,089,535
Market Cap: 12,023,374,829
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 8 10
Moderate Buy 1 1 1 1
Hold 5 6 5 4
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.07 1.93 1.75
Latest Dividend: 0.06
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 06/27/07
Price Earnings Ratio: 20.89
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
20.89 21.00 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.87% 49.27% 61.71%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 0.33 0.10
Net Income 19.80 1.76 0.40
EPS 24.60 3.97 0.70
Earnings for MYL:
EBITDA 1.65B
Revenue 6.80B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $0.68 $0.89 $2.88 $3.27
Number of Analysts 9 8 10 10
High Estimate $0.68 $0.92 $2.91 $3.57
Low Estimate $0.67 $0.85 $2.85 $3.14
Prior Year $0.60 $0.83 $2.59 $2.88
Growth Rate (Year over Year) 12.59% 7.23% 11.35% 13.42%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
CashRocket
CashRocket: $MYL January bull risk reversal trader is back today 5000X, also active Wednesday about 12500X
2 hours ago from TweetDeck
MitchellKWarren
MitchellKWarren: Yesterday's Smart Money report for unusual options activity http://t.co/7x2EkBJcUU $HPQ $JRCC $MYL $ZNGA $AAPL
1 day ago from web
financial8ball
financial8ball: $MYL: Favorable Verdict for Mylan, http://t.co/pCjVrAwNzY #stock #trade #investment #News #MYL
2 days ago from financial8ball
MitchellKWarren
MitchellKWarren: Today's Smart Money report for unusual options activity http://t.co/7x2EkBJcUU $HPQ $JRCC $MYL $ZNGA $AAPL
2 days ago from Twitter for iPad
DozenStocks
DozenStocks: Top Nasdaq100 #Stocks Performance $SPLS $MDLZ $ESRX $NTAP $STX $INTU $MYL $REGN $CTSH $MNST $BIIB $KRFT more@ http://t.co/YdSIjG11yN
2 days ago from CJ AutoTweeter
DozenStocks
DozenStocks: Top Nasdaq100 #Stocks Trend $SPLS $ESRX $STX $BIIB $KRFT $XLNX $SHLD $MYL $ATVI $CHRW $MDLZ $SIRI $SIAL $COST @ http://t.co/YdSIjG11yN
2 days ago from CJ AutoTweeter
LouisianaTrader
LouisianaTrader: $MYL on watch. Solid volume signature. 1st stage cup pattern here. http://t.co/AV66lMGrOI
2 days ago from Tweetbot for iOS
LSFinancial
LSFinancial: Call/Put Highest % volume changes: Calls: $NCT, $PFE, $BRLI, $ARCP, $SUPN. Puts: $PFE, $SCHW, $XLNX, $SFI, $MYL
2 days ago from HootSuite
Aanchal_Dhir
Aanchal_Dhir: RT @SeekingAlpha: Is There Value In Today's Stock Market? http://t.co/iFRoeiwHn2 $AFL $BAC $BMY $CAB $DIS $EBAY $GCI $HD $JPM $MRK $MYL $NKE $PFE
2 days ago from web
SeekingAlpha
SeekingAlpha: Is There Value In Today's Stock Market? http://t.co/iFRoeiwHn2 $AFL $BAC $BMY $CAB $DIS $EBAY $GCI $HD $JPM $MRK $MYL $NKE $PFE
2 days ago from Seeking Alpha

bearishMylan downgraded at Bernstein

Mar 25, 2013 | 6:51 AM EDT

MYL was downgraded from Outperform to Market Perform, Bernstein said. $33 price target. Company lacks near-term catalysts. 

updateBarclays Healthcare Conf.

Mar 13, 2013 | 6:57 AM EDT

Barclays Healthcare Conference

Loving the Rally?

By

Gary Dvorchak

 | Mar 11, 2013 | 9:30 AM EDT

Here is how I am picking apart the sectors looking for strong relative performance candidates.

bearishMylan was downgraded at Canaccord

Mar 11, 2013 | 8:36 AM EDT

MYL was downgraded to Neutral, said Canaccord. Fewer catalysts are ahead, making upside from here limited.

bullishMylan estimates, target boosted at Canaccord

Nov 28, 2012 | 8:14 AM EST

Shares of MYL now seen reaching $31, according to Canaccord Genuity. Estimates also upped, as the company will likely make an accretive acquisition or repurchase more stock. Buy rating. 

A Healthy Investment Idea

By

Kate Stalter

 | Nov 21, 2012 | 1:00 PM EST

The health sector is one the less-beaten-down areas amid market weakness.

bullishMylan upgraded at Leerink

Nov 16, 2012 | 8:07 AM EST

MYL was upgraded to Outperform from Market Perform, Leerink Swann said. $30 price target. Improved outlook on EpiPen and accretive transactions. 

bullishMylan upgraded at Canaccord

Oct 26, 2012 | 6:50 AM EDT

MYL was upgraded to Buy, Canaccord Genuity said. $30 price target. Company can deliver earnings upside in the coming quarters.

Boring Is Beautiful

By

Bret Jensen

 | Oct 1, 2012 | 11:00 AM EDT

Here are two generic-drug companies that should hold up well, regardless of the current uncertainty.

It's Just Healthy Profit-Taking

By

James "Rev Shark" DePorre

 | Aug 10, 2012 | 11:45 AM EDT

There's no reason to read much into it.

Columnist Conversation / Market Updates

TBT Inflection Point
By

Robert Moreno

 | May 24, 2013 | 11:19 AM EDT
The ProShares UltraShort 20+ Year Treasury (TBT) has been trading in a price channel for a year. This month it is, once ...

Two energy concerns get upgraded
By

Bret Jensen

 | May 24, 2013 | 9:29 AM EDT
A couple of fast growing E & P concerns get upgraded to end the week. Whiting Petroleum (WLL) sees its price target...
See more »

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.